![conference banner](/images/conference-banner.jpeg)
Abstract
Transgelins, which have been studied by proteomic methods for more than ten years as tumor-associated proteins, are the members of calponin family, since calponin homology domains are present in their amino acid sequences and there are other typical structural features. According to the available information there is a specific tissue distribution of these proteins. Three closely related genes which coded transgelins are revealed in the human genome. Single nucleotide substitutions and the expression peculiarities of these genes can be the reasons for existence of several isoforms of three main transgelins. Different manifestations of biochemical polymorphism of transgelins are detected by now. Transgelin (or SM22-alpha) is well known as a biomarker of smooth muscle cell differentiation. It was revealed that transgelin acts as repressor of MMP9 gene, coding matrix metalloproteinase-9. At the same time the oppositely directed changes in the content of transgelin proteins were found in tissue samples of malignant tumors of the respiratory, digestive and urogenital systems, as well as in the cultivated tumor cell using proteomic technologies. Correspondingly, according to some authors transgelins can be potential biomarkers of malignant neoplasms, but in the opinion the others – transgelins are suppressors of tumor growth. In this review, we consider possible reasons for such differences and discuss the prospects of solution of the existing contradictions.
Keywords: Cancer, members of calponin family, proteomic approaches, transgelins.
Current Proteomics
Title:Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers
Volume: 10 Issue: 2
Author(s): Sergey S. Shishkin, Marina A. Kovaleva, Lidia S. Eryomina, Ksenia V. Lisitskaya and Leonid I. Kovalev
Affiliation:
Keywords: Cancer, members of calponin family, proteomic approaches, transgelins.
Abstract: Transgelins, which have been studied by proteomic methods for more than ten years as tumor-associated proteins, are the members of calponin family, since calponin homology domains are present in their amino acid sequences and there are other typical structural features. According to the available information there is a specific tissue distribution of these proteins. Three closely related genes which coded transgelins are revealed in the human genome. Single nucleotide substitutions and the expression peculiarities of these genes can be the reasons for existence of several isoforms of three main transgelins. Different manifestations of biochemical polymorphism of transgelins are detected by now. Transgelin (or SM22-alpha) is well known as a biomarker of smooth muscle cell differentiation. It was revealed that transgelin acts as repressor of MMP9 gene, coding matrix metalloproteinase-9. At the same time the oppositely directed changes in the content of transgelin proteins were found in tissue samples of malignant tumors of the respiratory, digestive and urogenital systems, as well as in the cultivated tumor cell using proteomic technologies. Correspondingly, according to some authors transgelins can be potential biomarkers of malignant neoplasms, but in the opinion the others – transgelins are suppressors of tumor growth. In this review, we consider possible reasons for such differences and discuss the prospects of solution of the existing contradictions.
Export Options
About this article
Cite this article as:
Shishkin S. Sergey, Kovaleva A. Marina, Eryomina S. Lidia, Lisitskaya V. Ksenia and Kovalev I. Leonid, Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers, Current Proteomics 2013; 10 (2) . https://dx.doi.org/10.2174/1570164611310020008
DOI https://dx.doi.org/10.2174/1570164611310020008 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Machine Learning Based Computational Biology and Digital Medicine
Machine learning has become a major research topic with a wide range of applications, such as intelligent driving, public security, financial risk management, medical diagnosis, and computational biology. This Special Thematic Issue entitled: "Recent Trends in Machine Learning Based Computational Biology and Digital Medicine" aims to explore the scientific-technological frontiers ...read more
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Research Advancements in Porcine Derived Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms
Current Molecular Pharmacology Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage
Current Cancer Drug Targets Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Current Psychopharmacology Molecular Structural Characteristics of Estrogen Receptor Modulators as Determinants of Estrogen Receptor Selectivity
Mini-Reviews in Medicinal Chemistry PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
Current Medicinal Chemistry The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Current Cancer Therapy Reviews Imaging Tumor Metastases with Molecular Probes
Current Pharmaceutical Design Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Current Drug Targets Stem Cell Therapies
Recent Patents on Regenerative Medicine Meta-analysis Reveals No Association of DNMT3B -149 C>T Gene Polymorphism With Overall Cancer Risk
Current Genomics Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science How to Inhibit Telomerase Activity for Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line
Anti-Cancer Agents in Medicinal Chemistry Polymeric Nanoparticles of Aromatase Inhibitors: A Comprehensive Review
Current Pharmaceutical Design Essential Fatty Acids along the Women’s Life Cycle and Promotion of a Well-balanced Metabolism
Current Women`s Health Reviews Image Quality Improvement of Low-dose Abdominal CT using Deep Learning Image Reconstruction Compared with the Second Generation Iterative Reconstruction
Current Medical Imaging